Oxford-led research maps milestone stage of human development for the first time
25 November 2021
Scientists have shed light on an important stage of early embryonic development that has never been fully mapped out in humans before.
RDM researchers test potential treatment for fatigue in long COVID patients
29 October 2021
The Radcliffe Department of Medicine’s Dr Betty Raman is leading a new a phase 2a clinical trial to investigate whether a drug could treat the fatigue and muscle weakness experienced by many patients who have recovered from COVID.
Drug could help diabetic hearts recover after a heart attack
20 October 2021
New research led by Associate Professor Lisa Heather has found that a drug known as molidustat, currently in clinical trials for another condition, could reduce risk of heart failure after heart attacks.
Richard Tyser and Jack Miller honoured by the British Society of Cardiovascular Research
14 September 2021
Dr Richard Tyser is this year’s winner of the Bernard and Joan Marshall Early Career Investigator Prize, and Dr Jack Miller has received a runner-up award, at the British Society of Cardiovascular Research Autumn Meeting.
Xin Sun shortlisted in national science image competition
25 August 2021
DPAG Postdoctoral Research Scientist Dr Xin Sun has been shortlisted in the British Heart Foundation’s (BHF) annual ‘Reflections of Research’ image competition.
Reducing fat in the diabetic heart could improve recovery from heart attack
29 July 2021
New research from the Heather Group has shown that in type 2 diabetes an overload of lipids reduces the heart’s ability to generate energy during a heart attack, decreasing chances of recovery.
High blood sugar levels ‘reprogramme’ stem cells
14 July 2021
Findings explain higher risk of heart attack in people with diabetes, even after treatment .
Critical six-week window to ‘reset’ blood pressure after giving birth
28 June 2021
Home blood pressure monitors could help mothers significantly lower high blood pressure after pregnancy
Iron deficiency anaemia in early pregnancy increases risk of heart defects, suggests new research
8 June 2021
In animal models, iron deficient mothers have a greatly increased risk of having offspring with congenital heart disease (CHD). The risk of CHD can be greatly reduced if the mother is given iron supplements very early in pregnancy. Additionally, embryos from a mouse model of Down Syndrome were particularly vulnerable to the effects of maternal iron deficiency, leading to a higher risk of developing severe heart defects.
Filipa Simões – A Seat at the Table
3 June 2021
Intermediate Transition Research Fellow Dr Filipa Simões from The Riley Group has been interviewed by the British Heart Foundation for the BHF Alumni website, where she discusses her research career, being a woman in science and supporting underrepresented students.
Nicola Smart to deliver John French Lecture
2 June 2021
The British Atherosclerosis Society's John French Memorial Lecture is named in honour of the Oxford-based pathologist, Dr John French, who made seminal observations and contributions to the field of cardiovascular pathology.
Having a healthier heart associated with better problem-solving and reaction time
17 May 2021
People with healthier heart structure and function appear to have better cognitive abilities, including increased capacity to solve logic problems and faster reaction times, according to a study involving University of Oxford and Queen Mary University of London (QMUL) researchers.
Study provides new insights into causal mechanisms for atrial fibrillation
13 May 2021
A large-scale genetic study, led by Oxford BHF researchers Dr Parag Gajendragadkar, clinical DPhil student, Professor Barbara Casadei and Professor Jemma Hopewell, has shed new light on common heart rhythm disturbances
New target identified to develop treatment for Abdominal Aortic Aneurysm
30 March 2021
A new study from the Smart group has shed light on a key regulatory step in the initiation and progression of Abdominal Aortic Aneurysm by revealing the protective role of a previously little known small protein.
Travels with Vignesh
9 February 2021
Vignesh Murugesan, a Postdoctoral Researcher in Department of Physiology, Anatomy & Genetics (DPAG), describes how he found his way from the large metropolitan town of Chennai in India to studying regenerative medicine here in Oxford, via an 8 year stint in Sweden.